Louapre C, Ibrahim M, Maillart E, Abdi B, et al. Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients
with multiple sclerosis or neuromyelitis optica spectrum disorders. J Neurol Neurosurg Psychiatry 2021 Aug 2. pii: jnnp-2021-326904.
PMID: 34341142